PEQLX | VIVAX | PEQLX / VIVAX | |
Total Expense Ratio | 0.64 | 0.17 | 376% |
Annual Report Gross Expense Ratio | 0.64 | 0.17 | 376% |
Fund Existence | 13 years | 32 years | - |
Gain YTD | -3.501 | -3.517 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 34.5B | 191B | 18% |
Annual Yield % from dividends | 1.33 | 2.14 | 62% |
Returns for 1 year | 1.01 | 5.55 | 18% |
Returns for 3 years | 11.22 | 10.48 | 107% |
Returns for 5 years | 64.18 | 66.50 | 97% |
Returns for 10 years | 75.05 | 94.13 | 80% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBTM | 22.82 | 0.09 | +0.40% |
iShares iBonds Dec 2032 Term Trs ETF | |||
IYLD | 19.69 | 0.04 | +0.20% |
iShares Morningstar Multi-Asset Inc ETF | |||
NDIA | 27.93 | 0.05 | +0.18% |
Global X India Active ETF | |||
USMV | 89.83 | -1.02 | -1.12% |
iShares MSCI USA Min Vol Factor ETF | |||
FBT | 152.38 | -2.85 | -1.83% |
First Trust NYSE Arca Biotech ETF |